This list is an analysis based on recent market events. It's not an investment recommendation.
About
Biotechnology
Health Technology
Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. The company offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. Its products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. The company also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Cremorne, Australia.
Show more...
CEO
Mr. Michael Johnson
Country
AU
ISIN
AU000000RNO1
Listings
0 Comments
Share your thoughts
FAQ
What is Rhinomed Limited stock price today?▼
The current price of RHNMF is $0.02 USD — it has increased by +12.43% in the past 24 hours. Watch Rhinomed Limited stock price performance more closely on the chart.
What is Rhinomed Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Rhinomed Limited stocks are traded under the ticker RHNMF.
What were Rhinomed Limited earnings last quarter?▼
RHNMF earnings for the last quarter are -0 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Rhinomed Limited revenue for the last year?▼
Rhinomed Limited revenue for the last year amounts to 6.42M USD.
What is Rhinomed Limited net income for the last year?▼
RHNMF net income for the last year is -3.76M USD.
In which sector is Rhinomed Limited located?▼
Rhinomed Limited operates in the Healthcare sector.
When did Rhinomed Limited complete a stock split?▼
The last stock split for Rhinomed Limited was on May 15, 2017 with a ratio of 1:10.
Where is Rhinomed Limited headquartered?▼
Rhinomed Limited is headquartered in Cremorne, AU.